Sana Biotechnology
SANA
SANA
117 hedge funds and large institutions have $986M invested in Sana Biotechnology in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less call options, than puts
Call options by funds: $136K | Put options by funds: $141K
43% less capital invested
Capital invested by funds: $1.73B → $986M (-$741M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
117
Holding in Top 10
2
Calls
$136K
Puts
$141K
Top Buyers
| 1 | +$29.9M | |
| 2 | +$8.83M | |
| 3 | +$8.72M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.98M |
| 5 |
Renaissance Technologies
New York
|
+$6.47M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$23.2M | |
| 3 | -$1.91M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.46M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.35M |